Ergoteles LLC Eli Lilly & CO Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $192,901 - $226,553	621 Added 12.93%	5,425 $1.86 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $743,423 - $866,237	-2,312 Reduced 32.49%	4,804 $1.76 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.11 Million - $2.4 Million	7,116 New	7,116 $2.3 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $9.24 Million - $11.4 Million	-41,681 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $7.53 Million - $9.73 Million	41,681 New	41,681 $9.57 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $4.99 Million - $6.46 Million	-30,346 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $17.4 Million - $23.1 Million	-133,554 Reduced 81.49%	30,346 $5.12 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $24 Million - $27.7 Million	163,900 New	163,900 $24.3 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.